kabutan

RaQualia Pharma, Jan-Sep (Cumulative 3Q) Ordinary Profit Loss Widens, Jul-Sep Ordinary Profit Turns to Loss

Fri Nov 14, 2025 3:30 pm JST Earnings

4579 RaQualia Pharma Inc. 【J-GAAP】

Earnings Report

RaQualia Pharma Inc. <4579> [TSE Growth] announced its financial results after the market closed on November 14th (15:30). The consolidated ordinary loss for the cumulative third quarter of the fiscal year ending December 2025 (January to September) expanded to a loss of 426 million yen (compared to a loss of 231 million yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the October to December period (4Q) is expected to turn into a profit of 499 million yen (compared to a loss of 130 million yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated ordinary profit/loss turned to a loss of 135 million yen (compared to a profit of 46 million yen in the same period last year). The operating profit/loss margin drastically worsened from 13.3% in the same period last year to -19.8%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2023 1,495 -108 -36 -117 -5.5 ー Nov 10, 2023 J-GAAP
Jan - Sep, 2024 2,369 -27 -231 -339 -15.7 ー Nov 14, 2024 J-GAAP
Jan - Sep, 2025 2,311 -344 -426 -568 -24.3 ー Nov 14, 2025 J-GAAP
YoY -2.4% -1,174.1% -84.4% -67.6% -54.6%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 1,696 -59 -84 -172 -8.0 0 Feb 14, 2025 J-GAAP
Jul - Dec, 2025 Guidance 2,353 308 364 283 11.6 0 Aug 14, 2025 J-GAAP
YoY +38.7% － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 1,901 -337 -293 -323 -15.0 0 Feb 14, 2024 J-GAAP
Dec, 2024 3,107 -213 -361 -495 -22.9 0 Feb 14, 2025 J-GAAP
Dec, 2025 Guidance 3,888 118 73 -71 -2.9 0 Feb 14, 2025 J-GAAP
YoY +25.1% － － +85.7% +87.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 958 127 46 -16 -0.7 13.3 Nov 14, 2024 J-GAAP
Oct - Dec, 2024 738 -186 -130 -156 -7.2 -25.2 Feb 14, 2025 J-GAAP
Jan - Mar, 2025 965 93 29 -5 -0.2 9.6 May 15, 2025 J-GAAP
Apr - Jun, 2025 570 -283 -320 -349 -15.3 -49.6 Aug 14, 2025 J-GAAP
Jul - Sep, 2025 776 -154 -135 -214 -9.2 -19.8 Nov 14, 2025 J-GAAP
YoY -19.0% － － -1,237.5% -1,136.5%

Related Articles